Chemo combo shows promise against pancreatic cancer

NCT ID NCT02047474

First seen Mar 24, 2026 · Last updated May 14, 2026 · Updated 6 times

Summary

This study tested a combination of chemotherapy drugs given before and after surgery for people with early-stage pancreatic cancer. The goal was to shrink the tumor before surgery and kill any remaining cancer cells afterward. 46 participants were enrolled to see if this approach could help control the disease and improve survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACINAR CELL ADENOCARCINOMA OF THE PANCREAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Smilow Cancer Hospital at Fairfield

    Fairfield, Connecticut, 06824, United States

  • Smilow Cancer Hospital at Guilford

    Guilford, Connecticut, 06437, United States

  • Smilow Cancer Hospital at North Haven

    North Haven, Connecticut, 06473, United States

  • Smilow Cancer Hospital at Orange

    Orange, Connecticut, 06477, United States

  • Smilow Cancer Hospital at St. Francis Hospital

    Hartford, Connecticut, 06105, United States

  • Smilow Cancer Hospital at Torrington

    Torrington, Connecticut, 06790, United States

  • Smilow Cancer Hospital at Trumbull

    Trumbull, Connecticut, 06611, United States

  • Smilow Cancer Hospital at Waterbury

    Waterbury, Connecticut, 06708, United States

  • Yale University

    New Haven, Connecticut, 06520-8032, United States

Conditions

Explore the condition pages connected to this study.